Financial Information
- Company Name
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- CIK Code
- 818686
- SIC Code
- 2834
- Exchanges
- NYSE
- Tickers
- TEVA
| Date |
Revenue |
Operating Income |
Net Income |
Assets |
Liabilities |
Cash |
|---|
| Dec 22 |
$14,924,999,680 |
$2,099,000,064 |
$2,352,999,936 |
$44,005,998,592 |
$35,314,999,296 | $2,800,999,936 |
| Dec 21 |
$15,877,999,616 |
$1,716,000,000 |
$417,000,000 |
$47,665,999,872 |
$36,422,000,640 | $2,164,999,936 |
| Dec 20 |
$16,659,000,320 |
$3,572,000,000 |
$3,990,000,128 |
$50,639,998,976 |
$39,579,000,832 | $2,176,999,936 |
| Dec 19 |
$16,887,000,064 |
$443,000,000 |
$999,000,000 |
$57,470,001,152 |
$42,406,998,016 | $1,975,000,064 |
| Date | Equity | Retained Earnings | C. Assets | C. Liabilities | Dividends | Stock Outstanding |
|---|
| Dec 22 |
$7,896,999,936 | $12,881,999,872 | $12,051,000,320 | $11,468,999,680 | | 1,110,899,783 |
| Dec 21 |
$10,277,999,616 | $10,529,000,448 | $12,572,999,680 | $11,027,000,320 | | 1,103,329,696 |
| Dec 20 |
$10,026,000,384 | $10,945,999,872 | $13,004,999,680 | $13,164,000,256 | | 1,096,511,852 |
| Dec 19 |
$13,971,999,744 | $6,956,000,256 | $13,464,000,512 | $13,674,000,384 | | 1,092,189,007 |
Balance sheet values are in $USD. Not investment advice.
Recent TEVA Movement
2.75% Gain between 2024-03-15 and 2024-04-26.